Citadel Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,000
Closed -$971K 12982
2025
Q3
$971K Sell
32,000
-92,900
-74% -$2.82M ﹤0.01% 7591
2025
Q2
$3.92M Sell
124,900
-33,200
-21% -$1.1M ﹤0.01% 4520
2025
Q1
$6.04M Buy
158,100
+123,900
+362% +$5.26M ﹤0.01% 3579
2024
Q4
$1.5M Buy
34,200
+6,000
+21% +$264K ﹤0.01% 6228
2024
Q3
$1.21M Buy
28,200
+23,200
+464% +$1.03M ﹤0.01% 6466
2024
Q2
$226K Sell
5,000
-16,800
-77% -$872K ﹤0.01% 9672
2024
Q1
$1.36M Buy
21,800
+13,978
+179% +$836K ﹤0.01% 6289
2023
Q4
$438K Sell
7,822
-800
-9% -$39.9K ﹤0.01% 8386
2023
Q3
$455K Buy
8,622
+1,900
+28% +$111K ﹤0.01% 8259
2023
Q2
$431K Sell
6,722
-1,200
-15% -$68.3K ﹤0.01% 8264
2023
Q1
$424K Sell
7,922
-4,893
-38% -$284K ﹤0.01% 8645
2022
Q4
$686K Buy
12,815
+5,400
+73% +$279K ﹤0.01% 7583
2022
Q3
$342K Buy
+7,415
New +$402K ﹤0.01% 9282
2022
Q2
Sell
-7,495
Closed -$513K 13151
2022
Q1
$513K Sell
7,495
-6,159
-45% -$439K ﹤0.01% 9326
2021
Q4
$1.08M Sell
13,654
-17,313
-56% -$1.45M ﹤0.01% 7757
2021
Q3
$2.45M Buy
30,967
+8,192
+36% +$658K ﹤0.01% 5859
2021
Q2
$1.8M Sell
22,775
-7,088
-24% -$543K ﹤0.01% 6864
2021
Q1
$2.25M Sell
29,863
-126,368
-81% -$9.26M ﹤0.01% 6113
2020
Q4
$10.3M Buy
156,231
+134,095
+606% +$7.84M ﹤0.01% 2612
2020
Q3
$1.2M Buy
22,136
+11,678
+112% +$641K ﹤0.01% 5709
2020
Q2
$502K Sell
10,458
-3,137
-23% -$139K ﹤0.01% 7070
2020
Q1
$463K Sell
13,595
-3,022
-18% -$166K ﹤0.01% 6580
2019
Q4
$1.04M Sell
16,617
-35,499
-68% -$2.01M ﹤0.01% 5507
2019
Q3
$2.61M Buy
52,116
+25,739
+98% +$1.22M ﹤0.01% 4066
2019
Q2
$1.27M Sell
26,377
-1,802
-6% -$86.8K ﹤0.01% 5309
2019
Q1
$1.44M Buy
+28,179
New +$1.24M ﹤0.01% 4974
2018
Q4
Sell
-13,363
Closed -$829K 9261
2018
Q3
$829K Sell
13,363
-20,393
-60% -$1.16M ﹤0.01% 5860
2018
Q2
$1.78M Buy
33,756
+18,011
+114% +$973K ﹤0.01% 4288
2018
Q1
$864K Buy
15,745
+9,412
+149% +$580K ﹤0.01% 5029
2017
Q4
$432K Sell
6,333
-1,569
-20% -$106K ﹤0.01% 5875
2017
Q3
$566K Buy
7,902
+1,743
+28% +$121K ﹤0.01% 5143
2017
Q2
$417K Buy
6,159
+872
+16% +$59.5K ﹤0.01% 5379
2017
Q1
$357K Sell
5,287
-4,300
-45% -$287K ﹤0.01% 5606
2016
Q4
$593K Buy
9,587
+3,080
+47% +$182K ﹤0.01% 4635
2016
Q3
$352K Sell
6,507
-1,104
-15% -$55.6K ﹤0.01% 5401
2016
Q2
$347K Sell
7,611
-3,138
-29% -$153K ﹤0.01% 5006
2016
Q1
$529K Sell
10,749
-9,818
-48% -$418K ﹤0.01% 4337
2015
Q4
$827K Buy
20,567
+6,972
+51% +$320K ﹤0.01% 3817
2015
Q3
$700K Buy
13,595
+1,278
+10% +$84.8K ﹤0.01% 4305
2015
Q2
$978K Buy
12,317
+4,532
+58% +$384K ﹤0.01% 3985
2015
Q1
$640K Sell
7,785
-1,453
-16% -$122K ﹤0.01% 4546
2014
Q4
$820K Sell
9,238
-4,183
-31% -$379K ﹤0.01% 4014
2014
Q3
$1.32M Buy
13,421
+2,498
+23% +$281K ﹤0.01% 3363
2014
Q2
$1.4M Buy
10,923
+291
+3% +$36.3K ﹤0.01% 3091
2014
Q1
$1.3M Buy
10,632
+7,320
+221% +$841K ﹤0.01% 3096
2013
Q4
$363K Sell
3,312
-3,428
-51% -$343K ﹤0.01% 4405
2013
Q3
$655K Buy
6,740
+1,104
+20% +$102K ﹤0.01% 3531
2013
Q2
$505K Buy
+5,636
New +$465K ﹤0.01% 3840

Other funds holding ENOV

Citadel Advisors's ENOV Position: Q1 2026 in Review

Citadel Advisors increased its Enovis (ENOV) stake by 232% in Q1 2026, buying an estimated $12.9M and bringing the position to 781,761 shares worth $17.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Citadel Advisors first reported a position in ENOV in Q2 2013 and has held it in 49 quarters since. The position peaked at $78.4M in Q4 2017. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Citadel Advisors held 781,761 shares of Enovis worth $17.8M as of Q1 2026.
  • Citadel Advisors bought 546,383 Enovis shares in Q1 2026, an estimated $12.9M.
  • Enovis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2471 holding.
  • Citadel Advisors first reported a position in Enovis in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Enovis position peaked at $78.4M in Q4 2017.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.